Amerisource Health Services LLC, doing business as American Health Packaging, is recalling 4,971 cartons of Tizanidine (4 mg) tablets, a prescription medication used to manage muscle spasms. The recall was issued because the tablets failed dissolution testing, meaning they may not dissolve properly in the body as intended. If the medication does not dissolve correctly, it may not provide the necessary treatment or could lead to inconsistent drug levels in the patient's system. No injuries or incidents have been reported in connection with this recall.
If the tablets fail to dissolve at the required rate, the patient may not receive the full therapeutic benefit of the medication, potentially leading to ineffective management of muscle spasms. In some cases, improper dissolution can cause unpredictable absorption of the drug into the bloodstream.
You have 2 options:
Packaged and Distributed by American Health Packaging; Recalled due to manufacturer Dr. Reddy's Laboratories, Inc. failure of dissolution specifications.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.